Exscientia: Too Much Pessimism (NASDAQ:EXAI)

Molecular Structure


Exscientia plc (NASDAQ:EXAI) is one of a number of companies using AI to try and address the low returns on drug discovery investments. While this could create enormous value, there are still questions around AI’s overall impact on R&D efficiency, the

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *